Providence Capital Advisors, LLC
Position in ATHE — Alterity Therapeutics Ltd
CIK 1730814
CHARLOTTE, NC
Position in ATHE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,074
+$812 QoQ
Shares Held
200
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 22 holders
Holding Since
Sep 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ATHE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Providence Capital Advisors, LLC holds $11,720 across 3 Biotechnology names. ATHE ranks #2 (9.2% of the industry book) .
All Filings in ATHE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,074 | 200 | Shares | Sole | 2026-08-11 | |
| 2024-09-30 | $262 | 200 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $362 | 200 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $414 | 200 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $498 | 200 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $496 | 200 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $558 | 200 | Shares | Sole | 2023-08-10 | |
| 2022-12-31 | $700 | 2,000 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $880 | 2,000 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $1,220 | 2,000 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $1,660 | 2,000 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,440 | 2,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $2,540 | 2,000 | Shares | Sole | 2021-11-09 | |
| No filing history on record for this holder in this stock. | ||||||